The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Checkpoint Therapeutics, Inc(NASDAQ:CKPT) 
Checkpoint Therapeutics, Inc., a clinical-stage immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal ...
Website: http://www.checkpointtx.com
Founded: 2014
Full Time Employees: 8
CEO: James Oliviero
Sector: Healthcare
Industry: Biotechnology
Checkpoint Therapeutics Days Payable Outstanding ttm (DPO)
Checkpoint Therapeutics Days Receivable Outstanding ttm (DSO)
Checkpoint Therapeutics Op Cashflow Per Share ttm
Checkpoint Therapeutics Free Cashflow Per Share ttm
Checkpoint Therapeutics Cash Per Share ttm
Checkpoint Therapeutics P/S ratio ttm
Checkpoint Therapeutics (GAAP) P/E ratio ttm
Checkpoint Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.